Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma.

Hall J, Prabhakar S, Balaj L, Lai CP, Cerione RA, Breakefield XO.

Cell Mol Neurobiol. 2016 Apr;36(3):417-27. doi: 10.1007/s10571-015-0309-0. Review.

Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266.

Marthaler AG, Tubsuwan A, Schmid B, Poulsen UB, Engelbrecht AF, Mau-Holzmann UA, Hyttel P, Nielsen TT, Nielsen JE, Holst B.

Stem Cell Res. 2016 Jan;16(1):202-5. doi: 10.1016/j.scr.2015.12.048.

Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease).

El-Horany HE, El-Latif RN, ElBatsh MM, Emam MN.

J Biochem Mol Toxicol. 2016 Jul;30(7):360-9. doi: 10.1002/jbt.21821.

Clinical Characteristics of Voice, Speech, and Swallowing Disorders in Oromandibular Dystonia.

Kreisler A, Verpraet AC, Veit S, Pennel-Ployart O, Béhal H, Duhamel A, Destée A.

J Speech Lang Hear Res. 2016 Oct 1;59(5):940-949. doi: 10.1044/2016_JSLHR-S-15-0169.

Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease.

Yu CC, Chen MH, Lu CH, Huang YC, Chen HL, Tsai NW, Wang HC, Yang IH, Li SH, Lin WC.

Oxid Med Cell Longev. 2016;2016:1810289.

Resistance Training Reduces Force Tremor and Improves Manual Dexterity in Older Individuals With Essential Tremor.

Kavanagh JJ, Wedderburn-Bisshop J, Keogh JW.

J Mot Behav. 2016;48(1):20-30. doi: 10.1080/00222895.2015.1028583.

Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.

Blennow K, Biscetti L, Eusebi P, Parnetti L.

Mov Disord. 2016 Jun;31(6):836-47. doi: 10.1002/mds.26656. Review.

A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea.

Park H, Jeon BS, Shin JH, Park SH.

Parkinsonism Relat Disord. 2016 Jan;22:106-7. doi: 10.1016/j.parkreldis.2015.11.011. No abstract available.

Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.

Eftekhar P, Mochizuki G, Dutta T, Richardson D, Brooks D.

Occup Ther Int. 2016 Dec;23(4):379-389. doi: 10.1002/oti.1440.

Response to: Neurotoxicity of paraquat and paraquat-induced Parkinson's disease.

Thompson MD, Zhang XF.

Lab Invest. 2016 Sep;96(9):1030-4. doi: 10.1038/labinvest.2016.83. No abstract available.

Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease.

Zhang Y, Tan F, Xu P, Qu S.

Neural Plast. 2016;2016:8941327. doi: 10.1155/2016/8941327. Review.

A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects.

Beck DB, Cho MT, Millan F, Yates C, Hannibal M, O'Connor B, Shinawi M, Connolly AM, Waggoner D, Halbach S, Angle B, Sanders V, Shen Y, Retterer K, Begtrup A, Bai R, Chung WK.

Neurogenetics. 2016 Jul;17(3):173-8. doi: 10.1007/s10048-016-0482-4.

NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA.

Expert Opin Drug Metab Toxicol. 2016 Aug;12(8):937-46. doi: 10.1080/17425255.2016.1192127.

Speech-activated Myoclonus Mimicking Stuttering in a Patient with Myoclonus-Dystonia Syndrome.

Isaacs DA, Hedera P.

Tremor Other Hyperkinet Mov (N Y). 2016 Jul 1;6:405. doi: 10.7916/D8J966FP.

GBA p.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis.

Mallett V, Ross JP, Alcalay RN, Ambalavanan A, Sidransky E, Dion PA, Rouleau GA, Gan-Or Z.

Neurol Genet. 2016 Sep 8;2(5):e104. doi: 10.1212/NXG.0000000000000104.